Sientra, Inc. (SIEN)
$0.8227
Rating:
Recommendation:
Neutral
| Symbol | SIEN |
|---|---|
| Price | $0.8227 |
| Beta | 1.913 |
| Volume Avg. | 0.18M |
| Market Cap | 9.838M |
| Shares () | - |
| 52 Week Range | 0.588-4.937 |
| 1y Target Est | - |
| DCF Unlevered | SIEN DCF -> | |
|---|---|---|
| DCF Levered | SIEN LDCF -> | |
| ROE | 414.58% | Strong Buy |
| ROA | -45.91% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | -196.41% | Sell |
| P/E | -0.16 | Neutral |
| P/B | -0.29 | Neutral |
Latest SIEN news
About
Download (Excel)Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.